Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. L'Oréal
  6. News
  7. Summary
    OR   FR0000120321

L'ORÉAL

(OR)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Nestle trims L'Oreal stake with $10 billion sale

12/07/2021 | 07:05pm EST
FILE PHOTO: FILE PHOTO: Logo is pictured on the Nestle research center in Lausanne

By Mimosa Spencer and Gwénaëlle Barzic

PARIS (Reuters) -Nestle SA said on Tuesday it would cut its stake in L'Oreal to about 20% by selling shares worth 8.9 billion euros ($10 billion) back to the French cosmetics brand, moving to reduce the weight of the beauty giant on its books for the first time in 7 years.

The Nescafe maker's holding in the beauty giant has been subject of intense scrutiny over the years, and the Swiss company has maintained its interest was both financial and strategic, even when activist investor Third Point urged disposal in mid 2017. Since then, L'Oreal shares have more than doubled.

Seeking to reduce the weight of its L'Oreal holding while maintaining a level above 20%, allowing it to consolidate the investment on accounts, Nestle approached L'Oreal two months ago, kicking off a flurry of negotiations that involved chairmen of both companies, according to a source with knowledge of negotiations.

Following the deal, Nestle said it would own 20.1% of L'Oreal, down from 23.3% previously. L'Oreal, meanwhile, would buy back shares representing 4% of its capital and cancel them at the latest on Aug. 29.

L'Oreal, which is paying 400 euros per share, said the deal will have an accretive effect on the company's earnings per share of more than 4% in a full year. The beauty company is paying with cash and debt.

As a result of the transaction, which is expected to close in the coming days, the Bettencourt Meyers family, will see their stake rise to 34.7% from 33.3%, but will not be required to launch a takeover offer, as normally required for passing ownership thresholds above one-third of the capital.

L'Oréal stock ended Tuesday up 3.96% at 424.8 euros while Nestle gained 0.1% to 121.9 Swiss francs.

The packaged foods maker also said its board had decided to buy back 20 billion Swiss francs ($21.6 billion) worth of its shares between 2022 and 2024, adding that it would adjust this program should it make sizable acquisitions.

Nestle said it would terminate its current share repurchase plan by the end of the year, having bought back shares for 12.7 billion Swiss francs or almost two-thirds of the program volume.


L'Oreal around four years ago underscored https://reut.rs/3GqHqcP its readiness to buy Nestle's 23% stake if the Swiss shareholder was to sell it.

Nestle in October 2019 closed the sale of its skin health business for 10.2 billion Swiss francs, as the group moved to ditch underperforming businesses.

In 2014, Nestle reduced its holding from 31%.

Centerview acted as lead adviser to L'Oreal for the transaction announced Tuesday.

($1 = 0.8876 euros)

($1 = 0.9246 Swiss francs)

(Additional reporting by Praveen Paramasivam in Bengaluru; Editing by Ramakrishnan M. And Cynthia Osterman)


© Reuters 2021
All news about L'ORÉAL
01/21L'Oreal and Verily announce first-of-its-kind strategic partnership to advance precisio..
AQ
01/20L'Oreal Joins Alphabet's Verily to Research Skin Health
MT
01/20Alphabet's unprofitable Verily unit in skin-care deal with L'Oreal
RE
01/20L'OREAL : L'Oréal and Verily announce first-of-its-kind strategic partnership to advance p..
PU
01/20L'Oréal and Verily announce first-of-its-kind strategic partnership to advance precisio..
AQ
01/20L'Oréal and Verily Announce Strategic Partnership to Advance Precision Skin Health
CI
01/20LOREAL : Berenberg remains Neutral
MD
01/18LOREAL : UBS reiterates its Buy rating
MD
01/18LOREAL : Gets a Buy rating from JP Morgan
MD
01/17LOREAL : JP Morgan keeps its Buy rating
MD
More news
Analyst Recommendations on L'ORÉAL
More recommendations
Financials
Sales 2021 31 855 M 36 091 M 36 091 M
Net income 2021 4 512 M 5 112 M 5 112 M
Net cash 2021 6 358 M 7 204 M 7 204 M
P/E ratio 2021 45,8x
Yield 2021 1,22%
Capitalization 209 B 238 B 237 B
EV / Sales 2021 6,37x
EV / Sales 2022 5,75x
Nbr of Employees 85 392
Free-Float -
Chart L'ORÉAL
Duration : Period :
L'Oréal Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends L'ORÉAL
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 27
Last Close Price 375,50 €
Average target price 401,79 €
Spread / Average Target 7,00%
EPS Revisions
Managers and Directors
Nicolas Hieronimus Chief Executive Officer & Director
Christophe Babule Chief Financial Officer
Jean-Paul Agon Deputy Chief Executive Officer
Barbara Lavernos Deputy CEO-Research, Innovation & Technology
Antoine Vanlaeys Operations Director-Asia Pacific Zone
Sector and Competitors
1st jan.Capi. (M$)
L'ORÉAL-9.94%237 503
KAO CORPORATION-2.76%24 376
SHISEIDO COMPANY, LIMITED-7.45%20 841
AMOREPACIFIC CORPORATION-4.49%8 460
DCC PLC4.36%8 443
COTY INC.-20.10%7 035